BR9611206A - Utilização da proteína gax ou de uma variante da mesma e de pelo menos uma sequência nucleica que codifica completamente ou em parte a proteína gax ou de uma variante da mesma - Google Patents

Utilização da proteína gax ou de uma variante da mesma e de pelo menos uma sequência nucleica que codifica completamente ou em parte a proteína gax ou de uma variante da mesma

Info

Publication number
BR9611206A
BR9611206A BR9611206A BR9611206A BR9611206A BR 9611206 A BR9611206 A BR 9611206A BR 9611206 A BR9611206 A BR 9611206A BR 9611206 A BR9611206 A BR 9611206A BR 9611206 A BR9611206 A BR 9611206A
Authority
BR
Brazil
Prior art keywords
variant
gax protein
sequence encoding
nucleic sequence
completely
Prior art date
Application number
BR9611206A
Other languages
English (en)
Portuguese (pt)
Inventor
Patrice Denefle
Didier Branellec
Aude Leroux
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of BR9611206A publication Critical patent/BR9611206A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9611206A 1995-10-31 1996-10-28 Utilização da proteína gax ou de uma variante da mesma e de pelo menos uma sequência nucleica que codifica completamente ou em parte a proteína gax ou de uma variante da mesma BR9611206A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512871A FR2740344B1 (fr) 1995-10-31 1995-10-31 Application de la proteine gax au traitement de cancers
PCT/FR1996/001690 WO1997016459A1 (fr) 1995-10-31 1996-10-28 Application de la proteine gax au traitement de cancers

Publications (1)

Publication Number Publication Date
BR9611206A true BR9611206A (pt) 1999-03-30

Family

ID=9484112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611206A BR9611206A (pt) 1995-10-31 1996-10-28 Utilização da proteína gax ou de uma variante da mesma e de pelo menos uma sequência nucleica que codifica completamente ou em parte a proteína gax ou de uma variante da mesma

Country Status (13)

Country Link
EP (1) EP0858466A1 (fr)
JP (1) JPH11514881A (fr)
KR (1) KR19990067174A (fr)
AU (1) AU730324B2 (fr)
BR (1) BR9611206A (fr)
CA (1) CA2233250A1 (fr)
CZ (1) CZ131598A3 (fr)
FR (1) FR2740344B1 (fr)
HU (1) HUP9900011A3 (fr)
NO (1) NO981822L (fr)
SK (1) SK56198A3 (fr)
WO (1) WO1997016459A1 (fr)
ZA (1) ZA969147B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754822B1 (fr) * 1996-10-18 1998-11-27 Rhone Poulenc Rorer Sa Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations
WO2002000241A2 (fr) * 2000-06-28 2002-01-03 Aventis Pharma S.A. Compositions et procedes pour reguler le cycle cellulaire
KR101164602B1 (ko) 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신
WO2011055888A1 (fr) 2009-11-06 2011-05-12 Chung-Ang University Industry-Academy Cooperation Foundtion Systèmes de délivrance de gènes à base de nanoparticules
KR101232123B1 (ko) 2010-10-08 2013-02-12 연세대학교 산학협력단 재조합된 유전자발현 조절서열을 가지는 종양 특이적 발현이 개선된 유전자 전달체
KR101427200B1 (ko) 2011-11-24 2014-08-07 주식회사 바이로메드 아데노바이러스 생산 신규 세포주 및 그의 용도
KR101429696B1 (ko) 2012-11-21 2014-08-13 국립암센터 안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도
CN108289920A (zh) 2015-10-12 2018-07-17 汉阳大学校产学协力团 用于基因转移和基因治疗的腺病毒复合物
US11850215B2 (en) 2017-12-13 2023-12-26 Genemedicine Co., Ltd. Recombinant adenoviruses and stem cells comprising same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705361B1 (fr) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
FR2732357B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose

Also Published As

Publication number Publication date
NO981822D0 (no) 1998-04-23
KR19990067174A (ko) 1999-08-16
HUP9900011A2 (hu) 1999-04-28
JPH11514881A (ja) 1999-12-21
SK56198A3 (en) 1998-11-04
NO981822L (no) 1998-04-23
FR2740344B1 (fr) 1997-11-21
AU730324B2 (en) 2001-03-01
CA2233250A1 (fr) 1997-05-09
CZ131598A3 (cs) 1998-08-12
HUP9900011A3 (en) 1999-11-29
AU7498296A (en) 1997-05-22
ZA969147B (en) 1997-05-27
WO1997016459A1 (fr) 1997-05-09
FR2740344A1 (fr) 1997-04-30
EP0858466A1 (fr) 1998-08-19

Similar Documents

Publication Publication Date Title
DE69425670T2 (de) Nasenklappe/flügel-kombination
FI944310A0 (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
DE69408769D1 (de) Fliessbandsteuerung und Registerübersetzung in Mikroprozessor
EE9400174A (et) Ternespiima fraktsiooni sisaldav kompositsioon ja kasutamine
ITMI940438A0 (it) Valvola combinata
DE59401041D1 (de) Drosselklappenstutzen
BR9611206A (pt) Utilização da proteína gax ou de uma variante da mesma e de pelo menos uma sequência nucleica que codifica completamente ou em parte a proteína gax ou de uma variante da mesma
DE69400788T2 (de) Klappenventil
DE69433915D1 (de) MDC-Proteine und dafür kodierende DNS
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
ID21034A (id) Protein kinase dan penggunaannya
FI953763A (fi) Veteen liukeneva ja ilmassa kuivuva hartsi
KR950013377U (ko) 쑥뜸구
FI971085A0 (fi) Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja
DE59400892D1 (de) Lenkventil mit geschlossener Mitte
DE69416555D1 (de) Gashebel mit Sicherheitsstellung
DE59408563D1 (de) Redundanz-ISFET
KR950016363U (ko) 좌우 구분이 없는 신발
FIU930624U0 (fi) Ja/nej-svarkuvert
KR940020828U (ko) 후로링의 조이너 팻킹
KR950004011U (ko) 오목면 부분이 형성된 도어
KR950010930U (ko) 쑥뜸구
KR950009157U (ko) 도어스톱퍼
DE69334115D1 (de) CELP Kodierer und Dekodierer
BR6800811U (pt) Passatempo ludico e/ou educativo

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal